Deep Insight

Addionics Limited is a company focused on designing and developing advanced rechargeable batteries, primarily for electric vehicles. Founded in 2017 and headquartered in London, with an additional office in Tel-Aviv, Israel, Addionics specializes in innovative battery architecture that enhances energy density, reduces charging times, and improves thermal safety. The company utilizes a unique 3D battery architecture to minimize internal resistance and enhance mechanical longevity, thereby significantly improving overall battery performance. By transforming the physical structure of batteries at a microscopic level, Addionics aims to revolutionize energy storage and delivery, supporting battery manufacturers and automakers in producing safer, more efficient, and cost-effective energy solutions. The company's efforts are geared towards accelerating the development and scalability of its proprietary technology, contributing to a more sustainable future.

Magnus Metal Ltd. is an innovative company based in Nes Ziona, Israel, specializing in additive casting technology. It focuses on the development and manufacturing of metal parts through a digital process that enhances high-volume production capabilities. Magnus Metal provides metal casting services for a variety of applications, including industrial tooling, power train and engine assemblies, chassis, and structural components for robotics, heavy-duty machinery, vehicles, trucks, and trains. The company's advanced technology combines traditional casting methods with digital 3D printing techniques, allowing for design flexibility and multi-alloy capabilities. This approach results in improved product homogeneity, predictability, and accuracy, while also reducing costs per part for its clients.

Greeneye Technology is an innovative company based in Tel-Aviv, Israel, focused on transforming agricultural pest control through advanced technology. Established in 2017, Greeneye has developed a proprietary selective spraying system that employs artificial intelligence and machine learning to enable real-time detection of weeds, allowing for precise and targeted herbicide application. This approach significantly reduces herbicide usage by up to 90%, minimizing waste and promoting sustainable farming practices. The company boasts a multidisciplinary team with expertise in areas such as computer vision, agronomy, and mechanical engineering, all dedicated to providing effective and environmentally friendly solutions for farmers worldwide.

MediWound Ltd. is an integrated biopharmaceutical company based in Yavne, Israel, that specializes in developing, manufacturing, and commercializing innovative therapeutic products for severe burns and chronic wounds. Founded in 2000, the company is known for its flagship product, NexoBrid, which is an FDA-approved biopharmaceutical designed for the removal of eschar in adults with deep partial- and full-thickness thermal burns, offering a less invasive alternative to surgical interventions. MediWound also advances other product candidates, including EscharEx, which has completed Phase II clinical trials for the debridement of chronic and hard-to-heal wounds, and MWPC003 for connective tissue disorders. The company aims to address significant unmet medical needs in these areas and improve patient outcomes.

TriEye Ltd., established in 2017 and headquartered in Tel Aviv, Israel, specializes in developing Short Wave Infrared (SWIR) sensing solutions for autonomous vehicles. The company's core business involves creating CMOS-based SWIR sensors that enable clear imaging and accurate depth perception in challenging driving conditions such as darkness, rain, fog, and dust. TriEye's proprietary technology significantly reduces costs compared to existing industry rates while delivering reliable image data, thereby enhancing vehicle safety and autonomy.

Biond Biologics Ltd is a clinical-stage biopharmaceutical company based in Misgav, Israel, specializing in drug discovery and development for immuno-oncology and autoimmune diseases. Founded in 2016, Biond is focused on creating innovative therapies that address significant unmet medical needs. The company engages in extensive research to uncover immunoregulatory pathways and investigates immune checkpoints and immune-evasion mechanisms. Biond has developed a novel platform that targets intracellular immune factors, enabling the delivery of therapies for conditions previously considered undruggable. Through its commitment to high-quality science and innovation, Biond aims to advance the field of cancer immunotherapy and improve treatment options for patients.

Aviv Scientific is a leader in the longevity field, focusing on age-related cognitive and functional decline and novel applications of hyperbaric oxygen therapy (HBOT) to maximize human performance. Based on an exclusive partnership with the world’s largest hyperbaric medicine research facility, the Sagol Center at Shamir Medical Center in Israel, Aviv Scientific is introducing a global network of clinics delivering the most effective intervention available today for treating the aging process – The Aviv Medical Program. The three-month regimen has been proven to improve cognitive and physical performance in aging adults. For the first time, in depth comprehensive OMICS data detailing the aging process in healthy adults will be captured, expediting the development of therapeutics and approaches to notably extend healthspan, and ultimately lifespan, in humans.

Ramon.Space is a company focused on advancing space technology by providing Earth-like computing infrastructure for satellites. It develops resilient computing systems equipped with advanced storage, computing, and connectivity capabilities tailored for space applications. The company’s software-defined, low-power platform enables reliable data processing and storage in space, delivering real-time insights crucial for various missions. Its flexible and programmable architecture allows for optimized power usage and in-orbit software updates, enhancing adaptability and future-proofing for clients. From small satellites to deep space exploration, Ramon.Space's innovative computing products support the growing demand for smart and efficient space missions.

Rapid Medical Ltd. is a medical device company specializing in neurovascular interventional treatments aimed at addressing ischemic and hemorrhagic strokes. Founded in 2008 and headquartered in Yokne'am Illit, Israel, the company develops innovative products such as the Tigertriever, a revascularization device; DRIVEWIRE, a steerable guidewire designed for complex anatomical navigation; and Comaneci, a controllable device for managing aneurysm necks. Rapid Medical is dedicated to enhancing patient care by delivering high-quality, reliable medical devices that are easy to use and supported by robust clinical data. The company has established a distribution network across several countries in Europe, as well as in India, reflecting its commitment to expanding access to its advanced medical technologies.

Ramon.Space is a company focused on advancing space technology by providing Earth-like computing infrastructure for satellites. It develops resilient computing systems equipped with advanced storage, computing, and connectivity capabilities tailored for space applications. The company’s software-defined, low-power platform enables reliable data processing and storage in space, delivering real-time insights crucial for various missions. Its flexible and programmable architecture allows for optimized power usage and in-orbit software updates, enhancing adaptability and future-proofing for clients. From small satellites to deep space exploration, Ramon.Space's innovative computing products support the growing demand for smart and efficient space missions.